This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trompier, D. Articles by Baubichon-Cortay, H. Search for Related Content PubMed PubMed Citation Articles by Trompier, D. Articles by Baubichon-Cortay, H.

Verapamil and Its Derivative Trigger Apoptosis through Glutathione Extrusion by Multidrug Resistance Protein MRP1

¹ Laboratoire des Protéines de Résistance aux Agents Chimiothérapeutiques, Institut de Biologie et Chimie des Protéines, UMR 5086 Centre National de la Recherche Scientifique/Université Claude Bernard LYON 1, IFR 128 Biosciences Lyon-Gerland, Lyon, France; ² Mayo Clinic Scottsdale, S. C. Johnson Medical Research Center, Scottsdale, Arizona; and ³ Laboratoire de Chimie Biomimétique, LEDSS, UMR 5616 Centre National de la Recherche Scientifique/Université Joseph Fourier Grenoble I, Grenoble, France

This study demonstrates that verapamil and a newly synthesized verapamil derivative, NMeOHI₂, behave as apoptogens in multidrug resistance protein 1 (MRP1)-expressing cells. When treated with either verapamil or NMeOHI₂, surprisingly, baby hamster kidney-21 (BHK) cells transfected with human MRP1 were killed. Because parental BHK cells were not, as well as cells expressing an inactive (K1333L) MRP1 mutant, this indicated that cell death involved functional MRP1 transporter. Cell death was identified as apoptosis by using annexin V-fluorescein labeling and was no longer observed in the presence of the caspase inhibitor Z-Val-Ala-Asp(OMe)-CH₂F (Z-VAD-FMK). In vitro, both verapamil and its derivative inhibited leukotriene C4 transport by MRP1-enriched membrane vesicles in a competitive manner, with a K_i of 48.6 µM for verapamil and 5.5 µM for NMeOHI_2, and stimulated reduced glutathione (GSH) transport 3-fold and 9-fold, respectively. Treatment of MRP1-expressing cells with either verapamil or the derivative quickly depleted intracellular GSH content with a strong decrease occurring in the first hour of treatment, which preceded cell death beginning at 8–16 h. Furthermore, addition of GSH to the media efficiently prevented cell death. Therefore, verapamil and its derivative trigger apoptosis through stimulation of GSH extrusion mediated by MRP1. This new information on the mechanism of induced apoptosis of MDR cells may represent a novel approach in the selective treatment of MRP1-positive tumors.

This article has been cited by other articles:

				R. Franco, W. I. DeHaven, M. I. Sifre, C. D. Bortner, and J. A. Cidlowski Glutathione Depletion and Disruption of Intracellular Ionic Homeostasis Regulate Lymphoid Cell Apoptosis J. Biol. Chem., December 26, 2008; 283(52): 36071 - 36087. [Abstract] [Full Text] [PDF]

				G. Filomeni, P. Turella, M. L. Dupuis, O. Forini, M. R. Ciriolo, M. Cianfriglia, S. Pezzola, G. Federici, and A. M. Caccuri 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer Mol. Cancer Ther., February 1, 2008; 7(2): 371 - 379. [Abstract] [Full Text] [PDF]

				T. Perrotton, D. Trompier, X.-B. Chang, A. Di Pietro, and H. Baubichon-Cortay (R)- and (S)-Verapamil Differentially Modulate the Multidrug-resistant Protein MRP1 J. Biol. Chem., October 26, 2007; 282(43): 31542 - 31548. [Abstract] [Full Text] [PDF]

				A. Rothnie, R. Callaghan, R. G. Deeley, and S. P. C. Cole Role of GSH in Estrone Sulfate Binding and Translocation by the Multidrug Resistance Protein 1 (MRP1/ABCC1) J. Biol. Chem., May 19, 2006; 281(20): 13906 - 13914. [Abstract] [Full Text] [PDF]

				C. F.H. Mueller, J. D. Widder, J. S. McNally, L. McCann, D. P. Jones, and D. G. Harrison The Role of the Multidrug Resistance Protein-1 in Modulation of Endothelial Cell Oxidative Stress Circ. Res., September 30, 2005; 97(7): 637 - 644. [Abstract] [Full Text] [PDF]